Avenzo Therapeutics Announces Closing of Merger with Rallybio Corporation and Previously Announced $215 Million Concurrent Private Placement

BusinessWire
Avenzo Therapeutics Announces Closing of Merger with Rallybio Corporation and Previously Announced $215 Million Concurrent Private Placement
SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Announces Closing of Merger with Rallybio Corporation and Previously Announced $215 Million Concurrent Private Placement
Read the full story
This is a short summary. The complete article is published by BusinessWire.
Continue at BusinessWire

Headline and summary aggregated from public news feeds. For information only — not financial advice.